Evidence-based guideline summary: Diagnosis and treatment of limb-girdle and distal dystrophies: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine

Neurology

Volumn 83, Issue 16, 2014, Pages 1453-1463

  Narayanaswami, Pushpa ^a   Weiss, Michael ^b   Selcen, Duygu ^c   David, William ^a   Raynor, Elizabeth ^a   Carter, Gregory ^d   Wicklund, Matthew ^e   Barohn, Richard J ^f   Ensrud, Erik ^a,g   Griggs, Robert C ^h   Gronseth, Gary ^f   Amato, Anthony A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

^d St Luke's Rehabilitation Institute   (United States)

^e PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^f UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; NEUTRALIZING ANTIBODY;

AEROBIC EXERCISE; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; DISTAL MYOPATHY; ENDURANCE TRAINING; EVIDENCE BASED MEDICINE; GENE THERAPY; HUMAN; INHERITANCE; LIMB GIRDLE MUSCULAR DYSTROPHY; LUNG FUNCTION TEST; MEDICAL DECISION MAKING; MOLECULAR DIAGNOSIS; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; MYOBLAST TRANSPLANTATION; NEUROMUSCULAR DISEASE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RESISTANCE TRAINING; RESPIRATORY FAILURE; REVIEW; SAFETY; SPINE MALFORMATION; SYSTEMATIC REVIEW; DIFFERENTIAL DIAGNOSIS; GENETICS; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE;

DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; HUMANS; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHIES, LIMB-GIRDLE;

EID: 84924807538     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000892     Document Type: Review

References (40)

1. Walton JN, Nattrass FJ. On the classification, natural history and treatment of the myopathies. Brain 1954;77: 169-231.
2. Bushby KM. Diagnostic criteria for the limb-girdle muscular dystrophies: report of the ENMC Consortium on Limb-Girdle Dystrophies. Neuromuscul Disord 1995;5:71-74.
3. Bushby KM, Beckmann JS. The limb-girdle muscular dystrophies: proposal for a new nomenclature. Neuromuscul Disord 1995;5:337-343.
4. American Academy of Neurology. Guideline Development Process Manual, 2004 ed. St. Paul, MN: American Academy of Neurology; 2004.
5. American Academy of Neurology. Clinical Practice Guideline Process Manual, 2011 ed. St. Paul, MN: American Academy of Neurology; 2011.
6. Norwood FL, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain 2009;132:3175-3186.
7. Bushby KM, Thambyayah M, Gardner-Medwin D. Prevalence and incidence of Becker muscular dystrophy. Lancet 1991;337:1022-1024.
8. Siciliano G, Tessa A, Renna M, Manca ML, Mancuso M, Murri L. Epidemiology of dystrophinopathies in NorthWest Tuscany: a molecular genetics-based revisitation. Clin Genet 1999;56:51-58.
9. Nakagawa M, Nakahara K, Yoshidome H, et al. Epidemiology of progressive muscular dystrophy in Okinawa, Japan: classification with molecular biological techniques. Neuroepidemiology 1991;10:185-191.
10. Arikawa E, Hoffman EP, Kaido M, Nonaka I, Sugita H, Arahata K. The frequency of patients with dystrophin abnormalities in a limb-girdle patient population. Neurology 1991;41:1491-1496.
11. Kefi M, Amouri R, Driss A, et al. Phenotype and sarco-glycan expression in Tunisian LGMD 2C patients sharing the same del521-T mutation. Neuromuscul Disord 2003; 13:779-787.
12. Todorova A, Tournev I, Ninova N, Georgieva V, Kremensky I. Screening for C283Y gamma-sarcoglycan mutation in a high-risk group of Bulgarian Gypsies: evidence for a geographical localization and a non-random distribution among Gypsy subgroups. Community Genet 2002;5:217-221.
13. Merlini L, Kaplan JC, Navarro C, et al. The limb-girdle muscular dystrophy 2C in Gypsies. Acta Myol 2001;20: 188-191.
14. Spengos K, Walter MC, Dekomien G, Papadopoulos K, Lochmüller H, Manta P. C283Y mutation in the gamma-sarcoglycan gene in Greek Gypsies with severe limb girdle muscular dystrophy. Eur J Neurol 2010;17:e41-e42.
15. Godfrey C, Clement E, Mein R, et al. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain 2007;130: 2725-2735.
16. Biancheri R, Falace A, Tessa A, et al. POMT2 gene mutation in limb-girdle muscular dystrophy with inflammatory changes. Biochem Biophys Res Commun 2007;363: 1033-1037.
17. Hara Y, Balci-Hayta B, Yoshida-Moriguchi T, et al. A dystroglycan mutation associated with limb-girdle muscular dystrophy. N Engl J Med 2011;364:939-946.
18. Dinçer P, Balci B, Yuva Y, et al. A novel form of recessive limb girdle muscular dystrophy with mental retardation and abnormal expression of a-dystroglycan. Neuromuscul Disord 2003;13:771-778.
19. Schessl J, Taratuto AL, Sewry C, et al. Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1. Brain 2009;132:452-464.
20. Schoser B, Goebel HH, Janisch I, et al. Consequences of mutations within the C terminus of the FHL1 gene. Neurology 2009;73:543-551.
21. Shalaby S, Hayashi YK, Nonaka I, Noguchi S, Nishino I. Novel FHL1 mutations in fatal and benign reducing body myopathy. Neurology 2009;72:375-376.
22. Chen DH, Raskind WH, Parson WW, et al. A novel mutation in FHL1 in a family with X-linked scapuloper-oneal myopathy: phenotypic spectrum and structural study of FHL1 mutations. J Neurol Sci 2010;296:22-29.
23. Schessl J, Zou Y, McGrath MJ, et al. Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy. J Clin Invest 2008;118:904-912.
24. Sarkozy A, Windpassinger C, Hudson J, et al. Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene. Eur J Hum Genet 2011;19:1038-1044.
25. Selcen D, Muntoni F, Burton BK, et al. Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann Neurol 2009;65:83-89.
26. Odgerel Z, Sarkozy A, Lee HS, et al. Inheritance patterns and phenotypic features of myofibrillar myopathy associated with a BAG3 mutation. Neuromuscul Disord 2010; 20:438-442.
27. Olivé M, Odgerel Z, Martínez A, et al. Clinical and my-opathological evaluation of early- and late-onset subtypes of myofibrillar myopathy. Neuromuscul Disord 2011;21: 533-542.
28. Gilchrist JM, Pericak-Vance M, Silverman L, Roses AD. Clinical and genetic investigation in autosomal dominant limb-girdle muscular dystrophy. Neurology 1988;38:5-9.
29. Goldfarb LG, Park KY, Cervenáková L, et al. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet 1998;19:402-403.
30. Arias M, Pardo J, Blanco-Arias P, et al. Distinct pheno-typic features and gender-specific disease manifestations in a Spanish family with desmin L370P mutation. Neuro-muscul Disord 2006;16:498-503.
31. Bergman JE, Veenstra-Knol HE, van Essen AJ, et al. Two related Dutch families with a clinically variable presentation of cardioskeletal myopathy caused by a novel S13F mutation in the desmin gene. Eur J Med Genet 2007;50:355-366.
32. Dalakas MC, Dagvadorj A, Goudeau B, et al. Progressive skeletal myopathy, a phenotypic variant of desmin myop-athy associated with desmin mutations. Neuromuscul Dis-ord 2003;13:252-258.
33. Dalakas MC, Park KY, Semino-Mora C, Lee HS, Sivakumar K, Goldfarb LG. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med 2000;342:770-780.
34. Walter MC, Reilich P, Huebner A, et al. Scapuloperoneal syndrome type Kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P. Brain 2007;130:1485-1496.
35. Goudeau B, Rodrigues-Lima F, Fischer D, et al. Variable pathogenic potentials of mutations located in the desmin alpha-helical domain. Hum Mutat 2006;27:906-913.
36. Bär H, Goudeau B, Wälde S, et al. Conspicuous involvement of desmin tail mutations in diverse cardiac and skeletal myopathies. Hum Mutat 2007;28:374-376.
37. Dagvadorj A, Olivé M, Urtizberea JA, et al. A series of West European patients with severe cardiac and skeletal myopathy associated with a de novo R406W mutation in desmin. J Neurol 2004;251:143-149.
38. Olivé M, Armstrong J, Miralles F, et al. Phenotypic patterns of desminopathy associated with three novel mutations in the desmin gene. Neuromuscul Disord 2007;17:443-450.
39. Hong D, Wang Z, Zhang W, et al. A series of Chinese patients with desminopathy associated with six novel and one reported mutations in the desmin gene. Neuropathol Appl Neurobiol 2011;37:257-270.
40. Greenberg SA, Salajegheh M, Judge DP, et al. Etiology of limb girdle muscular dystrophy 1D/1E determined by laser capture microdissection proteomics. Ann Neurol 2012;71:141-145.